Postural effects on lung and chest wall volumes in late onset type II glycogenosis patients

Respiratory Physiology and Neurobiology

Volumn 186, Issue 3, 2013, Pages 308-314

  Remiche, Gauthier ^a,b   Lo Mauro, Antonella ^c   Tarsia, Paolo ^d   Ronchi, Dario ^d   Bordoni, Andreina ^d   Magri, Francesca ^d   Comi, Giacomo P ^d   Aliverti, Andrea ^c   D'Angelo, Maria Grazia ^e  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c POLITECNICO DI MILANO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Diaphragmatic weakness; Glycogen Storage Disease Type II (GSDII); Postural effects; Respiratory muscles; Spirometry

Indexed keywords

ABDOMINAL WALL MUSCULATURE; ADULT; ARTICLE; BODY POSTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPHRAGM; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LUNG FUNCTION; LUNG VOLUME; MALE; OXIMETRY; PRIORITY JOURNAL; SITTING; SPIROMETRY; SUPINE POSITION; THORAX; THORAX WALL; TOTAL LUNG CAPACITY;

ABDOMINAL MUSCLES; AGED; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; MUSCLE STRENGTH; PLETHYSMOGRAPHY; POSTURE; RESPIRATORY FUNCTION TESTS; SPIROMETRY; THORACIC WALL; TIDAL VOLUME; VITAL CAPACITY;

EID: 84876359955     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2013.03.004     Document Type: Article

References (21)

1. Aliverti A., Dellaca R., Pelosi P., Chiumello D., Gatihnoni L., Pedoti A. Compartmental analysis of breathing in the supine and prone positions by optoelectronic plethysmography. Annals of Biomedical Engineering 2001, 29:60-70.
2. Aliverti A., Dellaca R., Pelosi P., Chiumello D., Pedotti A., Gattinoni L. Optoelectronic plethysmography in intensive care patients. American Journal of Respiratory and Critical Care Medicine 2000, 161:1546-1552.
3. Cala S.J., Kenyon C.M., Ferrigno G., Carnevali P., Aliverti A., Pedotti A., Macklem P.T., Rochester D.F. Chest wall and lung volume estimation by optical reflectance motion analysis. Journal of Applied Physiology 1996, 81:2680-2689.
4. Carlier R.Y., Laforet P., Wary C., Mompoint D., Laloui K., Pellegrini N., Annane D., Carlier P.G., Orlikowski D. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns. Neuromuscular Disorders 2011, 21:791-799.
5. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., Stromberg A., van Veldhuisen D.J., Atar D., Hoes A.W., Keren A., Mebazaa A., Nieminen M., Priori S.G., Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Journal of Heart Failure 2008, 10:933-989.
6. Fromageot C., Lofaso F., Annane D., Falaize L., Lejaille M., Clair B., Gajdos P., Raphael J.C. Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Archives of Physical Medicine and Rehabilitation 2001, 82:123-128.
7. Lo Mauro A., D'Angelo M.G., Romei M., Motta F., Colombo D., Comi G.P., Pedotti A., Marchi E., Turconi A.C., Bresolin N., Aliverti A. Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in Duchenne muscular dystrophy. European Respiratory Journal 2010, 35:1118-1125.
8. Mellies U., Ragette R., Schwake C., Baethmann M., Voit T., Teschler H. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001, 57:1290-1295.
9. Pellegrini N., Laforet P., Orlikowski D., Pellegrini M., Caillaud C., Eymard B., Raphael J.C., Lofaso F. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. European Respiratory Journal 2005, 26:1024-1031.
10. Pichiecchio A., Uggetti C., Ravaglia S., Egitto M.G., Rossi M., Sandrini G., Danesino C. Muscle MRI in adult-onset acid maltase deficiency. Neuromuscular Disorders 2004, 14:51-55.
11. Prigent H., Orlikowski D., Laforet P., Letilly N., Falaize L., Pellegrini N., Annane D., Raphael J.C., Lofaso F. Supine volume drop and diaphragmatic function in adults with Pompe disease. European Respiratory Journal 2012, 39:1545-1546.
12. Romei M., D'Angelo M.G., LoMauro A., Gandossini S., Bonato S., Brighina E., Marchi E., Comi G.P., Turconi A.C., Pedotti A., Bresolin N., Aliverti A. Low abdominal contribution to breathing as daytime predictor of nocturnal desaturation in adolescents and young adults with Duchenne Muscular Dystrophy. Respiratory Medicine 2012, 106:276-283.
13. Sharma G., Goodwin J. Effect of aging on respiratory system physiology and immunology. Clinical Interventions in Aging 2006, 1:253-260.
14. Sorenson E.J., Windbank A.J., Mandrekar J.N., Bamlet W.R., Appel S.H., Armon C., Barkhaus P.E., Bosch P., Boylan K., David W.S., Feldman E., Glass J., Gutmann L., Katz J., King W., Luciano C.A., McCluskey L.F., Nash S., Newman D.S., Pascuzzi R.M., Pioro E., Sams L.J., Scelsa S., Simpson E.P., Subramony S.H., Tiryaki E., Thornton C.A. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 2008, 71:1770-1775.
15. Strothotte S., Strigl-Pill N., Grunert B., Kornblum C., Eger K., Wessig C., Deschauer M., Breunig F., Glocker F.X., Vielhaber S., Brejova A., Hilz M., Reiners K., Muller-Felber W., Mengel E., Spranger M., Schoser B. Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. Journal of Neurology 2010, 257:91-97.
16. Van der Beek N.A., Hagemans M.L., Reuser A.J., Hop W.C., Van der Ploeg A.T., Van Doorn P.A., Wokke J.H. Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscular Disorders 2009, 19:113-117.
17. van der Beek N.A., van Capelle C.I., van der Velden-van Etten K.I., Hop W.C., van den Berg B., Reuser A.J., van Doorn P.A., van der Ploeg A.T., Stam H. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease. Molecular Genetics and Metabolism 2011, 104:129-136.
18. van der Ploeg A.T. Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives. European Respiratory Journal 2005, 26:984-985.
19. van der Ploeg A.T., Reuser A.J. Pompe's disease. Lancet 2008, 372:1342-1353.
20. Watson R.A., Pride N.B., Thomas E.L., Fitzpatrick J., Durighel G., McCarthy J., Morin S.X., Ind P.W., Bell J.D. Reduction of total lung capacity in obese men: comparison of total intrathoracic and gas volumes. Journal of Applied Physiology 2010, 108:1605-1612.
21. Wokke J.H., Escolar D.M., Pestronk A., Jaffe K.M., Carter G.T., van den Berg L.H., Florence J.M., Mayhew J., Skrinar A., Corzo D., Laforet P. Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle and Nerve 2008, 38:1236-1245.